Month: June 2022

MONTRÉAL, June 09, 2022 (GLOBE NEWSWIRE) — Bombardier Inc. (TSX: BBD.B) (“Bombardier” or the “Corporation”) confirmed today that the previously announced consolidation of the Corporation’s issued and unissued Class A shares (multiple voting) (the “Class A shares”) and Class B shares (subordinate voting) (the “Class B shares”) at a ratio of one (1) post-consolidation share for every twenty-five (25) pre-consolidation Class A shares or Class B shares (the “Share Consolidation”) is being implemented and will be effective on June 13, 2022 (the “Effective Date”). As such, the Corporation’s Class A shares and Class B shares are expected to begin trading on the TSX, on a consolidated basis, on or about the Effective Date. As previously announced, the Class A shares and Class B shares will continue to be listed on the TSX under the symbols...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 09, 2022 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) (“WWT” or the “Company“), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers is pleased to update that the due diligence process on the acquisition (see press releases dated January 12, 2022 and April 5, 2022) of Desarrollo De Sistemas Hidraulicos SA (“Hidrotop“) is progressing in a positive manner and the parties are in final stages of negotiating the definitive terms of the purchase and sale (the “SPA“). The parties expect to sign a definitive SPA on or prior to June 30, 2022. The SPA will provide that closing of the acquisition will...

Immunocore Appoints Siddharth Kaul to its Board of Directors (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 9 June 2022) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, autoimmune and infectious diseases, today announces the appointment of Siddharth (Sid) Kaul as a non-Executive member of its Board of Directors, effective June 8, 2022. Sid will serve as a Class II director and also serve as a member of the Audit and Remuneration committees. Sid is a seasoned finance professional with deep expertise within the life sciences industry. He retired as Group Treasurer and Head of Business Planning...

Los Angeles, CA., June 09, 2022 (GLOBE NEWSWIRE) — CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), an award-winning, full-service blockchain platform provider, is pleased to announce that its Motoclub.io platform is set to release its newest NFT pack in the Barrett-Jackson Scottsdale 2022 Collector Series – the “Platinum Pack”. This marks the third NFT pack drop in the four-pack Barrett-Jackson Scottsdale Series. The “Scottsdale Platinum Pack” includes fully tradable collector NFTs of vehicles sold at Barrett-Jackson’s January 2022 Scottsdale Auction. With each subsequent pack drop, the quantity of NFTs minted is reduced. Increasing the scarcity encourages Motoclub members to then engage with buying, selling, and trading their NFTs on its platform, which in turn drives incremental revenues for...

IRVINE, Calif., June 09, 2022 (GLOBE NEWSWIRE) — CalAmp (Nasdaq: CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced that it will release its fiscal 2023 first quarter financial results after the market close on Thursday, June 23, 2022. In addition, the Company will host a conference call at 5:00 p.m. Eastern (2:00 p.m. Pacific) on June 23, 2022 to discuss its financial results. The conference call may be accessed via webcast by visiting the Investor Relations section of CalAmp’s website at www.calamp.com. Please go to the website at least 15 minutes early to register, download and install any necessary audio software. A replay of the webcast will be available for 90 days after the call. The conference call can also...

Connexa Sports Technologies Inc. Connexa Sports Expands Partnership With IMG AcademyConnexa Sports secures a key partnership in its flagship sport of tennis; PlaySight’s industry-standard video tech will drive live streaming and performance tech capabilities on all 55 tennis courts BALTIMORE, June 09, 2022 (GLOBE NEWSWIRE) — Connexa Sports Technologies Inc. (OTCQB: CNXA) (www.connexasports.com) is pleased to announce that its wholly owned subsidiary, PlaySight Interactive (www.playsight.com) is expanding its partnership with the world-renowned IMG Academy. PlaySight first partnered with IMG Academy back in 2020 through its baseball program, who rely on PlaySight’s pioneering sports technology platform for live streaming, remote scouting, and recruiting, as well as player performance and film breakdowns. With the expansion to...

VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — XR Immersive Tech Inc. (“Immersive Tech”, or the “Company”) (CSE:VRAR) (FSE:79W) (OTCQB: FNTTF) is pleased to announce that the Company’s recently acquired subsidiary, SynthesisVR Inc. (“Synthesis VR”), a leading location-based virtual reality (“LBVR”) content distribution and facility management platform, has released its new VR streaming product to VR arcades worldwide through a co-development partnership with QuarkXR, a pioneering company focused on VR streaming and a trusted solution provider for companies like Deutsche Telekom, Orange, Vodafone, and Ericsson, among others. The SynthesisVR / QuarkXR streaming product offers all Location-based VR (LBVR) arcade operators a simple, and automated VR streaming solution, previously not available in the market. A solution...

Favorable tolerability with no grade 3/4 neutropenia and encouraging anti-tumor activity across Phase 1b monotherapy expansion Combinability with CDK4/6i palbociclib demonstrated across initial dose escalation cohorts, including no dose limiting toxicities and no induced metabolism of palbociclib Rapidly advancing the development of OP-1250 for ER+ / HER2- breast cancer with pivotal monotherapy study planned for 2023 initiationSAN FRANCISCO, June 09, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA) today announced clinical development progress for OP-1250, a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD) in development for the treatment of metastatic breast cancer. “We are extremely pleased with the emerging clinical profile of OP-1250 and...

HOUSTON, Texas, June 09, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today announced that the Company will participate in the 2022 BIO International Convention in San Diego from June 13-16, 2022. During the conference, attended by over 15,000 industry leaders, members of the Salarius team will provide updates on its two drug candidates, the Targeted Protein Degrader SP-3164 and the Protein Inhibitor seclidemstat. SP-3164 is a next-generation targeted protein degrader that induces selective elimination of cancer-causing proteins and is being investigated by Salarius as a potential treatment for hematological cancers and solid tumors. Seclidemstat is Salarius’ lead clinical candidate, which...